Eyenovia Inc.

1.84+0.0200+1.10%Vol 134.27K1Y Perf -66.30%
Jun 27th, 2022 16:00 DELAYED
BID1.73 ASK1.87
Open1.79 Previous Close1.82
Pre-Market- After-Market1.74
 - -  -0.10 -5.43%
Target Price
14.00 
Analyst Rating
Strong Buy 1.00
Potential %
660.87 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★+     43.06
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
★★     44.18
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
4.58 
Earnings Rating
Neutral
Market Cap61.77M 
Earnings Date
10th Aug 2022
Alpha-0.02 Standard Deviation0.22
Beta2.08 

Today's Price Range

1.761.87

52W Range

1.616.63

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
3.37%
1 Month
-21.70%
3 Months
-38.67%
6 Months
-52.58%
1 Year
-66.30%
3 Years
-57.21%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
EYEN1.840.02001.10
AAPL141.660.00000.00
GOOG2 332.45-38.3100-1.62
MSFT264.89-2.8100-1.05
XOM89.032.13002.45
WFC40.24-0.5200-1.28
JNJ182.12-0.1700-0.09
FB196.640.99000.51
GE66.71-0.2900-0.43
JPM116.38-0.9400-0.80
Financial StrengthValueIndustryS&P 500US Markets
2.80
2.90
0.44
0.26
-27.00
Leverage Ratio 2.00
ProfitabilityValueIndustryS&P 500US Markets
93.30
-118.70
-116.50
-
-61.89
RevenueValueIndustryS&P 500US Markets
12.00M
0.36
-
-
Earnings HistoryEstimateReportedSurprise %
Q01 2022--0.24-
Q04 2021-0.10-
Q03 2021-0.26-0.2311.54
Q02 2021-0.24-0.1920.83
Q01 2021-0.22-0.214.55
Q04 2020-0.21-0.1719.05
Q03 2020-0.14-0.23-64.29
Q02 2020-0.21-0.25-19.05
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.18--
9/2022 QR-0.18--
12/2022 FY-0.82--
12/2023 FY-0.75--
Next Report Date10th Aug 2022
Estimated EPS Next Report-0.18
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume134.27K
Shares Outstanding33.57K
Shares Float27.50M
Trades Count855
Dollar Volume243.20K
Avg. Volume169.57K
Avg. Weekly Volume252.97K
Avg. Monthly Volume131.21K
Avg. Quarterly Volume124.53K

Eyenovia Inc. (NASDAQ: EYEN) stock closed at 1.84 per share at the end of the most recent trading day (a 1.1% change compared to the prior day closing price) with a volume of 134.27K shares and market capitalization of 61.77M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 29 people. Eyenovia Inc. CEO is Tsontcho Ianchulev.

The one-year performance of Eyenovia Inc. stock is -66.3%, while year-to-date (YTD) performance is -54%. EYEN stock has a five-year performance of %. Its 52-week range is between 1.61 and 6.63, which gives EYEN stock a 52-week price range ratio of 4.58%

Eyenovia Inc. currently has a PE ratio of -3.50, a price-to-book (PB) ratio of 2.05, a price-to-sale (PS) ratio of 5.15, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -42.78%, a ROC of -56.44% and a ROE of -70.43%. The company’s profit margin is -61.89%, its EBITDA margin is -116.50%, and its revenue ttm is $12.00 Million , which makes it $0.36 revenue per share.

Of the last four earnings reports from Eyenovia Inc., there were 2 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.18 for the next earnings report. Eyenovia Inc.’s next earnings report date is 10th Aug 2022.

The consensus rating of Wall Street analysts for Eyenovia Inc. is Strong Buy (1), with a target price of $14, which is +660.87% compared to the current price. The earnings rating for Eyenovia Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Eyenovia Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Eyenovia Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 14.13, ATR14 : 0.19, CCI20 : -70.66, Chaikin Money Flow : -0.31, MACD : -0.14, Money Flow Index : 38.97, ROC : -16.13, RSI : 37.67, STOCH (14,3) : 29.17, STOCH RSI : 1.00, UO : 30.59, Williams %R : -70.83), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Eyenovia Inc. in the last 12-months were: Charles E. Mather (Buy at a value of $42 006), Kenneth B. Lee (Buy at a value of $22 000), Michael M. Rowe (Buy at a value of $11 568), Stuart M. Grant (Buy at a value of $425 750), Tsontcho Ianchulev (Buy at a value of $121 206)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
0
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0
Hold
0 (0.00 %)
0 (0.00 %)
0
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0
Strong Sell
0 (0.00 %)
0 (0.00 %)
0
Summary RatingStrong Buy
1.00
Strong Buy
1.00
-
0.00

Eyenovia Inc.

Eyenovia Inc is a clinical-stage biopharmaceutical company operating in the US. It is engaged in developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver micro-therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. The pipeline products of the company are MicroProst for chronic angle closure glaucoma, MicroStat for pharmacologic mydriasis, MicroTears for dry eye and MicroPine for myopia.

CEO: Tsontcho Ianchulev

Telephone: +1 917 289-1117

Address: 295 Madison Avenue, New York 10017, NY, US

Number of employees: 29

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

50%50%

Bearish Bullish

51%49%

News

Stocktwits